Women's Health Collection

Journal article

The effect of Indigenous American genomic ancestry on type 2 diabetes in Mexico: an analysis of 134 548 individuals from the Mexico City Prospective Study

Abstract:: Background: The prevalence of type 2 diabetes in Mexico is among the highest in the world and a major public health problem. The aim of this study was to examine the association between the percentage of Indigenous American genomic ancestry (AMR) and the prevalence of both prediabetes and type 2 diabetes in a large study of Mexican adults.

Methods: In this cross-sectional study, we analysed data from 134 548 individuals from the Mexico City Prospec...
Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Berumen, J., Kuri-Morales, P., Torres, J. M., Aguilar-Ramirez, D., Gnatiuc Friedrichs, L., & Emberson, J. R. (2026). The effect of Indigenous American genomic ancestry on type 2 diabetes in Mexico: an analysis of 134 548 individuals from the Mexico City Prospective Study. Lancet Public Health, 11(2), e111–e119.

MLA Style

Berumen, J, et al. “The Effect of Indigenous American Genomic Ancestry on Type 2 Diabetes in Mexico: an Analysis of 134 548 Individuals from the Mexico City Prospective Study.” Lancet Public Health, vol. 11, no. 2, 2026, pp. e111–e119.

Chicago Style

Berumen, J, P Kuri-Morales, JM Torres, D Aguilar-Ramirez, L Gnatiuc Friedrichs, and JR Emberson. 2026. “The Effect of Indigenous American Genomic Ancestry on Type 2 Diabetes in Mexico: an Analysis of 134 548 Individuals from the Mexico City Prospective Study.” Lancet Public Health 11 (2): e111–e119.
Print

Access Document

Files:: Berumen_et_al_2026_The_effect_of_SI.pdf

(Preview, Supplementary materials, pdf, 375.2KB, Terms of use)

Berumen_et_al_2026_The_effect_of.pdf

(Preview, Version of record, pdf, 680.2KB, Terms of use)

Publisher copy:: 10.1016/S2468-2667(25)00305-6

Authors

+ Berumen, J More by this author

Role:: Author

+ Kuri-Morales, P More by this author

Role:: Author

+ Torres, JM More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Nuffield Department of Population Health
Sub department:: Clinical Trial Service Unit
Role:: Author

+ Aguilar-Ramirez, D More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Nuffield Department of Population Health
Sub department:: Clinical Trial Service Unit
Role:: Author

+ Gnatiuc Friedrichs, L More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Nuffield Department of Population Health
Sub department:: Clinical Trial Service Unit
Role:: Author

More authors...

+ Medical Research Council More from this funder

Funder identifier:: https://ror.org/03x94j517
Grant:: MC_UU_00017/2; MR/Z504543/1

Publisher:: Elsevier
Journal:: Lancet Public Health More from this journal
Volume:: 11
Issue:: 2
Pages:: e111-e119
Publication date:: 2026-02-01
Acceptance date:: 2025-12-11
DOI:: 10.1016/S2468-2667(25)00305-6
EISSN:: 2468-2667

Language:: English
Pubs id:: 2349512
Local pid:: pubs:2349512
Deposit date:: 2025-12-12
ARK identifier:: ark:/29072/ora_cf5db3fda8f94756af2fb298422bfae6

Terms of use

Copyright holder:: Berumen et al.
Copyright date:: 2026
Rights statement:: © 2026 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.

Licence:: CC Attribution (CC BY)

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP